| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031072147 |
| P356 | DOI | 10.1038/227609B0 |
| P698 | PubMed publication ID | 5464249 |
| P2093 | author name string | Olney JW | |
| Ho OL | |||
| P2860 | cites work | The toxic effect of sodium L-glutamate on the inner layers of the retina. | Q33969485 |
| Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate | Q34054189 | ||
| Brain lesions in an infant rhesus monkey treated with monsodium glutamate | Q34240164 | ||
| Central synaptic transmission--microelectrophoretic studies | Q39891192 | ||
| Monosodium Glutamate: Specific Brain Lesion Questioned | Q43463881 | ||
| Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion | Q72397927 | ||
| Monosodium Glutamate | Q72442304 | ||
| Permanent fractionation of the electroretinogram by sodium glutamate | Q78978510 | ||
| P433 | issue | 5258 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 609-611 | |
| P577 | publication date | 1970-08-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine | |
| P478 | volume | 227 |
| Q36916674 | A role for excitatory amino acids in diabetic eye disease. |
| Q34252213 | Absorption, utilization, and safety of aspartic acid |
| Q51121394 | Acute effect of oral and subcutaneous administration of monosodium glutamate on the arcuate nucleus of the hypothalamus in mice and rats. |
| Q61913964 | Addressing comments by JD Fernstrom |
| Q33596258 | Age-related gray matter shrinkage in a treatment naïve actively drinking alcohol-dependent sample |
| Q40101029 | Aloe-emodin suppressed NMDA-induced apoptosis of retinal ganglion cells through regulation of ERK phosphorylation |
| Q23901998 | Aspartame: A Safety Evaluation Based on Current Use Levels, Regulations, and Toxicological and Epidemiological Studies |
| Q48137152 | Aspartate-induced neuronal necrosis in infant mice: protective effect of carbohydrate and insulin |
| Q34592271 | Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study |
| Q36873703 | Astroglia: important mediators of traumatic brain injury |
| Q44898003 | Axon-sparing brain lesioning technique: the use of monosodium-L-glutamate and other amino acids |
| Q35859614 | Barrier mechanisms in the developing brain. |
| Q48787383 | Biochemical changes of brain and liver in neonatal offspring of rats fed monosodium-L-glutamate |
| Q57611597 | Biotoxinas marinas: intoxicaciones por el consumo de moluscos bivalvos/Seafood toxins: poisoning by bivalve consumption |
| Q48343748 | Brain and retinal damage from lathyrus excitotoxin, beta-N-oxalyl-L-alpha,beta-diaminopropionic acid |
| Q48471822 | Brain damage and associated behavioral deficits following the administration of L-cysteine to infant rats |
| Q43807479 | Brain damage in neonatal mice following monosodium glutamate administration: Possible involvement of hypernatremia and hyperosmolality |
| Q48430034 | Brain injury after neonatal hypoxia-ischemia in rats: a role of cysteine? |
| Q34983973 | Consumption of monosodium glutamate in relation to incidence of overweight in Chinese adults: China Health and Nutrition Survey (CHNS) |
| Q49065683 | Contributing mechanisms for cysteine excitotoxicity in cultured cerebellar granule cells |
| Q47880244 | Cysteine dioxygenase: regional expression of activity in rat brain |
| Q48720320 | Cysteine-induced brain damage in infant and fetal rodents |
| Q48966069 | Cysteine-induced effect on amino acids in neonatal rat brain |
| Q48860477 | Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system |
| Q37100088 | Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia |
| Q73501599 | Development of a liquid chromatographic method for picomole determination of S-sulfocysteine in trifluoroacetic acid extracts of neonatal rat brain |
| Q57982877 | Development of brain damage after neonatal hypoxia-ischemia: Excitatory amino acids and cysteine |
| Q44556842 | Dietary L-aspartate and L-glutamate inhibit fatty streak initiation in cholesterol-fed rabbit |
| Q70800043 | Drinking behavior and the development of hypothalamic lesions from aspartame ingestion in water-restricted weanling mice |
| Q44600257 | Early loss of astrocytes after experimental traumatic brain injury |
| Q41534554 | Effect of Aspartame Loading on Plasma and Erythrocyte Free Amino Acid Concentrations in One-Year-Old Infants |
| Q66889254 | Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acids in normal adult volunteers |
| Q70566946 | Effect of diets fortified with dl-methionine on urinary and plasma methionine levels in young infants |
| Q72570053 | Effect of meal components on peripheral and portal plasma glutamate levels in young pigs administered large doses of monosodium-L-glutamate |
| Q48853262 | Effect of melatonin, piperonyl butoxide, or cobalt chloride on L-cysteine-induced lipid peroxidation in homogenate from whole brain of mice |
| Q72543007 | Effects of a parenteral nutrition regimen containing dicarboxylic amino acids on plasma, erythrocyte, and urinary amino acid concentrations of young infants |
| Q71684607 | Effects of cysteine and N-acetyl cysteine on GSH content of brain of adult rats |
| Q36847926 | Effects of maternal oral administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain |
| Q35023011 | Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity |
| Q48330786 | Electro-acupuncture protects against hypoxic–ischemic brain-damaged immature rat via hydrogen sulfide as a possible mediator |
| Q39523356 | Excitotoxic food additives: functional teratological aspects |
| Q35927885 | Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency |
| Q33861820 | Excitotoxicity in neurological disorders--the glutamate paradox |
| Q45734053 | Experimental studies on the ultrastructural localization of acetylcholinesterase in the mediobasal hypothalamus of the rat |
| Q24558984 | Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults |
| Q40091373 | Flavor potentiators |
| Q34785105 | Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain |
| Q47906106 | Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy |
| Q34234913 | Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity |
| Q48631676 | Glutamate accumulation in infant mouse hypothalamus: Influence of temperature |
| Q52027152 | Glutamate and aspartate impair memory retention and damage hypothalamic neurons in adult mice. |
| Q28259105 | Glutamate in neurologic diseases |
| Q33723529 | Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus |
| Q28190140 | Glutamate uptake |
| Q40205958 | Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation |
| Q68821656 | Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy |
| Q39276188 | Glutamine synthetase activity in vivo and in primary cell cultures of rat hypothalamus |
| Q33834183 | High extracellular glutamate and neuronal death in neurological disorders. Cause, contribution or consequence? |
| Q41541275 | Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis |
| Q45234638 | Immunohistochemical, Ultrastructural, and Hormonal Studies on the Endocrine Pancreas of Voles (Microtus arvalis) with Monosodium Aspartate-induced Diabetes |
| Q91981746 | Impact of Supplementary Amino Acids, Micronutrients, and Overall Diet on Glutathione Homeostasis |
| Q41777426 | Increased cerebral (R)-[(11)C]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study |
| Q93817625 | Infusion of protein hydrolysates in the newborn infant: plasma amino acid concentrations |
| Q24530151 | Interaction of L-cysteine with a human excitatory amino acid transporter |
| Q86651915 | Intraperitoneal injection of sulfur amino acids enhance the hepatic cysteine dioxygenase activity in rainbow trout (Oncorhynchus mykiss) |
| Q40408915 | Ion channels involved in stroke |
| Q39791521 | Kainic acid: Neurophysiological and neurotoxic actions |
| Q44623990 | L-cysteine increases glucose uptake in mouse soleus muscle and SH-SY5Y cells |
| Q48769265 | Lack of an effect of dietary monosodium-l-glutamate on some glutamate-metabolizing enzymes in developing rat brain |
| Q36874373 | Limitations of autopsy data in relating neonatal intracranial hemorrhage to buffer therapy |
| Q61797203 | Lipectomy associated to obesity produces greater fat accumulation in the visceral white adipose tissue of female compared to male rats |
| Q44574417 | Long-term neurobehavioral and histological damage in brain of mice induced by L-cysteine |
| Q90344015 | Loss of insulin-like growth factor-1 signaling in astrocytes disrupts glutamate handling |
| Q34074255 | Mechanisms of L-cysteine neurotoxicity |
| Q48924284 | Melatonin attenuates L-cysteine-induced seizures and lipid peroxidation in the brain of mice |
| Q44100440 | Modulation of glial glutamate transport through cell interactions with the extracellular matrix |
| Q27306725 | Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach |
| Q43410781 | Monosodium Glutamate Intolerance in Children |
| Q69945224 | Monosodium Glutamate induces Convulsive Disorders in Rats |
| Q44610120 | Monosodium glutamate studies in four species of neonatal and infant animals |
| Q51119979 | Monosodium l-glutamate—Inhibition of glucose uptake in brain as a basis for toxicity |
| Q37190678 | N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain |
| Q44086508 | NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria |
| Q48686031 | Neonatal aspartate treatment: effects on arcuate nucleus morphology, organ weights, and reproductive function |
| Q71154555 | Nephrotoxic effect of MSG (monosodium glutamate) in the chicken |
| Q42467798 | Net efflux of cysteine, glutathione and related metabolites from rat hippocampal slices during oxygen/glucose deprivation: dependence on gamma-glutamyl transpeptidase |
| Q37180770 | Neuroprotection in glaucoma: drug-based approaches. |
| Q38086728 | Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1). |
| Q41993780 | Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions |
| Q34264114 | New horizons in neuroprotection |
| Q94661028 | Nitric oxide donating anti-glaucoma drugs: advances and prospects |
| Q28205804 | Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors |
| Q54228931 | Nutritional effects of intravenous infusion solutions on normal rats: effects of increased energy level and deletion of acidic amino acids. |
| Q38090368 | Opioid administration following spinal cord injury: implications for pain and locomotor recovery |
| Q22251042 | Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond |
| Q47303632 | Plasma and erythrocyte amino acid levels of adult humans given 100 mg/kg body weight aspartame |
| Q51655757 | Plasma and erythrocyte concentrations of free amino acids in adult humans administered abuse doses of aspartame |
| Q47286691 | Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/kg body weight |
| Q35174032 | Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage |
| Q44348409 | Prolonged glutamate excitotoxicity: effects on mitochondrial antioxidants and antioxidant enzymes |
| Q33845365 | Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity |
| Q48421034 | Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatum. |
| Q44639770 | Rapid alteration of synaptic number and postsynaptic thickening length by NMDA: An electorn microscopic study in the occipital cortex of postnatral rats |
| Q71993009 | Regional brain glutamate transport in rats at normal and raised concentrations of circulating glutamate |
| Q34312980 | Review: taurine: a "very essential" amino acid. |
| Q47160004 | Re‐evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives |
| Q64973365 | Risk Assessment Paradigm for Glutamate. |
| Q37689215 | Role of cyclic AMP in the eye with glaucoma. |
| Q80975738 | S-sulfo-cysteine is an endogenous amino acid in neonatal rat brain but an unlikely mediator of cysteine neurotoxicity |
| Q30462209 | Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI) |
| Q33903298 | Saving the nerve from glaucoma: memantine to caspaces |
| Q38008213 | Sex and steroid hormones in early brain injury |
| Q48769087 | Sex- and dose-dependent effects of neonatally administered aspartate on the ultradian patterns of circulating growth hormone regulating hexobarbital metabolism and action |
| Q41650062 | Studies of hypoxemic/reoxygenation injury: without aortic clamping. VIII. Counteraction of oxidant damage by exogenous glutamate and aspartate |
| Q47382978 | Subcutaneous administration of monosodium glutamate to pregnant mice reduces weight gain in pups during lactation |
| Q37301646 | Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma |
| Q71079874 | Taurine and Tapetum Structure |
| Q54310319 | The Effect on Blood Biochemical Factors of a ICR-Mice in a High-Fat Diet with Taurine 20. |
| Q28248958 | The chemical biology of clinically tolerated NMDA receptor antagonists |
| Q66904389 | The induction of obesity in rodents by means of monosodium glutamate |
| Q44533502 | The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: glial-neuronal metabolic interactions |
| Q28649752 | The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history |
| Q47834640 | Toxicity of protein hydrolysate solutions: Correlation of glutamate dose and neuronal necrosis to plasma amino acid levels in young mice |
| Q35221438 | Transport via SLC5A8 (SMCT1) is obligatory for 2-oxothiazolidine-4-carboxylate to enhance glutathione production in retinal pigment epithelial cells |
| Q72476233 | Uptake of Exogenous Glutamate and Aspartate by Circumventricular Organs but Not Other Regions of Brain |
| Q45132275 | Use of an oral elemental diet in infants with severe intractable diarrhea |
Search more.